Rachelle Gordon

The path to cannabis rescheduling hit a new milestone this week when the acting Attorney General, Todd Blanche, signed an order immediately moving FDA-approved cannabis products and state-licensed medical marijuana from Schedule I to Schedule III. Later this summer, the Trump administration is expected to convene hearings to determine whether to complete the broader rescheduling of cannabis.

The path to cannabis rescheduling hit a new milestone this week when the acting Attorney General, Todd Blanche, signed an order immediately moving

A new poll suggests cannabis consumers have a shifting priority when shopping for pot - and it's not potency.

Half a decade after Virginia legalized adult-use cannabis, a regulated marketplace has yet to exist. Advocates believed dispensaries were finally on the way after voters elected cannabis-friendly Gov. Abigail Spanberger and lawmakers approved legislation months later. Now, the Commonwealth’s legal cannabis market appears to be in jeopardy again amid a conflict between Spanberger and lawmakers.

Most data and anecdotal reports suggest cannabis consumers have one main priority: potency.

The cannabis industry was jolted when the Trump administration announced it would immediately reclassify state-licensed medical marijuana.

Psilocybin (aka magic mushrooms) is becoming more common as communities enact drug policy reform and research increases. From Silicon Valley entrepreneurs to suburban parents, ‘shrooms are increasingly visible in mainstream culture. Reality star and makeup mogul Kylie Jenner is the latest to share about her mushroom experience.

State-specific campaigns to repeal adult-use cannabis legalization appear to be faltering, but prohibitionists remain steadfast.

While news of rescheduling has dominated the U.S. cannabis news cycle, discerning eyes are also looking overseas.

The hemp clock is ticking. Lawmakers have less than six months before a new law changing the federal definition of hemp is set to take effect. If implemented as written, the change would likely remove most hemp-derived products, including full-spectrum CBD oil and THC beverages, from the legal market. Now, three separate hemp amendments have been filed in Congress meant to preserve most of the industry.